“lung-cancer” Archives

Entry Author Date Location
Clovis Oncology Shares Plummet on FDA Request for More Data 11/16/15 Boulder/Denver
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
Enlitic CEO: Deep-Learning Software Could Soon Help Diagnose Patients 10/27/15 San Francisco
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? 08/04/15 National
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers 06/30/15 Wisconsin
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More 06/19/15 San Francisco
Exact Sciences, MD Anderson Developing Blood Tests For Lung Cancer 06/04/15 Wisconsin
At Exelixis, Morrissey Dreams Of Getting the Band Back Together 06/01/15 San Francisco
Armune Bioscience Develops First Cancer-Specific Prostate Test 05/28/15 Detroit Ann Arbor
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
A Few Raindrops Amid Texas Biotech IPO Drought 05/30/14 Texas
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
Deal Aims to Grow “Humanized” Organs in Pigs for Transplantation 05/06/14 San Diego
Indi Reels In $47M To Push Launch Of Lung Cancer Diagnostic 04/29/14 Seattle
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
Enzymatics Snares Boulder-based ArcherDx For Diagnostics Play 09/06/13 Boston
Clovis Oncology Closes $275M Offering Following Two Pivotal Weeks 06/18/13 Boulder/Denver
Clovis Oncology Boosts Public Offering to $240M After Stock Booms 06/12/13 Boulder/Denver
Clovis Oncology to Raise $170M as Stock Price Booms Following ASCO 06/10/13 Boulder/Denver
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
Ziopharm Goes Lean to Stretch Funds for New Synthetic Biology Focus 04/09/13 New York
Cerulean Pharma Fails to Extend Lives in Lung Cancer Study 03/22/13 Boston
Page 1 of 3 next page »